Article Detail - JE Part B
MolDX Draft LCDs - (DL38143, DL38147, DL38155) Published for Review and Comments
The following three draft JEB MolDX Local Coverage Determinations (LCDs) have been published for review and comments for contract numbers: 01112 (NCA), 01182 (SCA), 01212 (HI, and Territories) and 01312 (NV).
|Medicare Coverage Database Number||LCD Title|
|DL38143||MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Favorable Intermediate Risk Disease|
|DL38147||MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Unfavorable Intermediate Risk Disease|
|DL38155||Lab: Drug Interaction Testing|
Comment Period: May 30, 2019 – July 15, 2019
Go to the CMS MCD to access Proposed LCDs not released to final LCDs.
- Locate/select relevant listed LCD title(s)
Providers may address details for comment submission. When sending comments, reference the specific policy to which they are related. See the Draft LCDs webpage for email and mail specifics.
Last Updated Thu, 16 May 2019 10:17:46 +0000